Second Phase 1 trial of OTX-TIC in the United States

Trial Profile

Second Phase 1 trial of OTX-TIC in the United States

Planning
Phase of Trial: Phase I

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs Travoprost (Primary)
  • Indications Glaucoma; Ocular hypertension
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Nov 2017 New trial record
    • 07 Nov 2017 According to an Ocular Therapeutix media release, an Investigational New Drug (IND) application is expected to submit in the first quarter of 2018 and plans to initiate this trial in the first half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top